TLDR FDA approved BYSANTI (milsaperidone) for Bipolar I manic episodes and Schizophrenia in adults VNDA stock jumped up to 44% after-hours on the news Patent protection runs to 2044, blocking generic competition for nearly two decades Second FDA approval…